Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026)

Accuray (ARAY) reported Liabilities and Shareholders Equity of $447.6 million for Q1 2026, up 137.41% on a YoY basis from $188.5 million in Q1 2025, and up 139.68% quarter-over-quarter from $186.7 million in Q4 2025.

Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Accuray has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $447.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 137.41% year-over-year to $447.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 141.99% YoY), and the FY2025 full-year result was $470.2 million, up 229.7% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $447.6 million, up from $186.7 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $470.2 million in Q2 2025, with the low at $90.7 million in Q2 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $184.0 million across 5 years, with a median of $121.3 million in 2023.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity decreased 1.31% — and 2025, when it jumped 229.7%.
  • Accuray's Liabilities and Shareholders Equity stood at $105.4 million in 2022, then gained by 15.12% to $121.3 million in 2023, then surged by 31.08% to $159.0 million in 2024, then rose by 17.44% to $186.7 million in 2025, then jumped by 139.68% to $447.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $447.6 million (Q1 2026), $186.7 million (Q4 2025), and $456.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Accuray 41,092.55 -38.49 Mn 25.29 Mn 447.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 447.60 Mn
Dec 31, 2025 186.75 Mn
Sep 30, 2025 456.82 Mn
Jun 30, 2025 470.24 Mn
Mar 31, 2025 188.54 Mn
Dec 31, 2024 159.01 Mn
Sep 30, 2024 155.06 Mn
Jun 30, 2024 142.63 Mn
Mar 31, 2024 114.93 Mn
Dec 31, 2023 121.31 Mn
Sep 30, 2023 108.08 Mn
Jun 30, 2023 90.74 Mn
Mar 31, 2023 104.17 Mn
Dec 31, 2022 105.37 Mn
Sep 30, 2022 92.18 Mn
Jun 30, 2022 91.94 Mn
Mar 31, 2022 93.48 Mn
Dec 31, 2021 84.46 Mn
Sep 30, 2021 81.93 Mn
Jun 30, 2021 54.52 Mn